saplin

DSP Healthcare Fund

DSP Healthcare Fund (Direct, Growth): saplin Score 7.5/10 (Neutral) among 14 Sectoral/Thematic funds. 3Y return 21.9% a year vs 21.9% category median, expense ratio 0.75%. Uneven returns hold this fund back. NAV ₹52.84 on 11 Nov 2026.

Loading the full analysis…

Questions about DSP Healthcare Fund

What is the expense ratio of DSP Healthcare Fund?

The Direct plan's total expense ratio is 0.75% a year, against a median of 1.04% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages DSP Healthcare Fund?

Chirag Dagli (since 1 Dec 2020).

What are the top holdings of DSP Healthcare Fund?

Apollo Hospitals Enterprise 7.89%, IPCA Laboratories 7.49%, Cipla 7.40%, Sun Pharmaceutical Industries 7.32%, Gland Pharma 6.61% of the portfolio, as of 31 Oct 2026.

What returns has DSP Healthcare Fund given?

1 year: 19.7% (category median 21.9%); 3 years: 21.9% a year (category median 21.9%); 5 years: 17.4% a year (category median 16.8%). Past returns do not predict future ones.

How big is DSP Healthcare Fund?

About ₹3,721 cr (AMFI's average for the latest quarter).

How does DSP Healthcare Fund score?

7.5 out of 10 (Neutral) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.

More on DSP Healthcare